These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 36527302)

  • 41. Management of primary graft failure after heart transplantation: Preoperative risks, perioperative events, and postoperative decisions.
    Truby LK; DeRoo S; Spellman J; Jennings DL; Takeda K; Fine B; Restaino S; Farr M
    Clin Transplant; 2019 Jun; 33(6):e13557. PubMed ID: 30933386
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Impact of donor age on cardiac transplantation outcomes and on cardiac function.
    Chamogeorgakis T; Joseph S; Hall S; Gonzalez-Stawinski GV; Saracino G; Rafael A; MacHannaford J; Toumpoulis I; Mendez J; Lima B
    Interact Cardiovasc Thorac Surg; 2016 Oct; 23(4):580-3. PubMed ID: 27252239
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Heart transplantation outcomes from cardiac arrest-resuscitated donors.
    Quader MA; Wolfe LG; Kasirajan V
    J Heart Lung Transplant; 2013 Nov; 32(11):1090-5. PubMed ID: 23994219
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Influence of Transplant Center Procedural Volume on Survival Outcomes of Heart Transplantation for Children Bridged with Mechanical Circulatory Support.
    Hsieh A; Tumin D; McConnell PI; Galantowicz M; Tobias JD; Hayes D
    Pediatr Cardiol; 2017 Feb; 38(2):280-288. PubMed ID: 27882424
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Outcomes after heart transplantation in sensitized patients bridged with ventricular assist devices.
    Fraser CD; Zhou X; Magruder JT; Suarez-Pierre A; Lui C; Grimm JC; Higgins R; Kilic A
    J Card Surg; 2019 Jun; 34(6):474-481. PubMed ID: 31045281
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ventricular Assist Device Support as a Bridge to Transplantation in Pediatric Patients.
    Dipchand AI; Kirk R; Naftel DC; Pruitt E; Blume ED; Morrow R; Rosenthal D; Auerbach S; Richmond ME; Kirklin JK;
    J Am Coll Cardiol; 2018 Jul; 72(4):402-415. PubMed ID: 30025576
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Six-months immunogenicity of BNT162b2 mRNA vaccine in heart transplanted and ventricle assist device-supported patients.
    Itzhaki Ben Zadok O; Shaul AA; Ben-Avraham B; Yaari V; Ben Zvi H; Eliakim-Raz N; Yahav D; Abed G; Abuhazira M; Barac YD; Mats I; Shochat T; Aravot D; Kornowski R; Ben-Gal T
    ESC Heart Fail; 2022 Apr; 9(2):905-911. PubMed ID: 34981657
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Trends in the use of mechanical circulatory support as a bridge to heart transplantation across different age groups.
    Ciarka A; Edwards L; Nilsson J; Stehlik J; Lund LH
    Int J Cardiol; 2017 Mar; 231():225-227. PubMed ID: 27776746
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Donor and transplant candidate selection for solid organ transplantation during the COVID-19 pandemic.
    Galvan NTN; Moreno NF; Garza JE; Bourgeois S; Hemmersbach-Miller M; Murthy B; Timmins K; O'Mahony CA; Anton J; Civitello A; Garcha P; Loor G; Liao K; Shaffi A; Vierling J; Stribling R; Rana A; Goss JA
    Am J Transplant; 2020 Nov; 20(11):3113-3122. PubMed ID: 32524743
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dynamics and prognostic role of galectin-3 in patients with advanced heart failure, during left ventricular assist device support and following heart transplantation.
    Coromilas E; Que-Xu EC; Moore D; Kato TS; Wu C; Ji R; Givens R; Jorde UP; Takayama H; Naka Y; George I; Mancini D; Schulze PC
    BMC Cardiovasc Disord; 2016 Jun; 16():138. PubMed ID: 27301475
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of COVID-19 Pandemic on Complications and Mortality in the Early Postoperative Period After Heart Transplantation.
    Wajda-Pokrontka M; Nadziakiewicz P; Przybyłowski P
    Transplant Proc; 2024 May; 56(4):841-845. PubMed ID: 38714371
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Proposal for updated listing criteria for heart transplantation and indications to implant of left ventricular assist devices].
    Ammirati E; Oliva F; Colombo T; Botta L; Cipriani M; Cannata A; Verde A; Turazza FM; Russo CF; Paino R; Martinelli L; Frigerio M
    G Ital Cardiol (Rome); 2013 Feb; 14(2):110-9. PubMed ID: 23389313
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The pediatric mechanical circulatory support program in Innsbruck, Austria, and the impact of such programs on lack of donor hearts in Europe.
    Schweigmann U; Antretter H; Mair P; Velik-Salchner C; Margreiter J; Brunnemann J; Schermer E; Engl G; Hoermann C; Hoefer D; Kilo J; Laufer G; Stein JI; Geiger R; Rahmel A; Slot M; Cottogni M
    ASAIO J; 2007; 53(6):696-700. PubMed ID: 18043150
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparing Cardiac Mechanics and Myocardial Fibrosis in DBD and DCD Heart Transplant Recipients.
    Burrage MK; Cheshire C; Hey CY; Azam S; Watson WD; Bhagra S; Berman M; D'Errico L; Jenkins DP; Kaul P; Large S; Lewis C; Martinez L; Messer S; Page A; Parameshwar J; Pettit S; Rafiq M; Tsui S; Tweed K; Weir-McCall JR; Kydd A
    J Card Fail; 2023 May; 29(5):834-840. PubMed ID: 36521726
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pulsatile left ventricular assist device support as a bridge to decision in patients with end-stage heart failure complicated by pulmonary hypertension.
    Nair PK; Kormos RL; Teuteberg JJ; Mathier MA; Bermudez CA; Toyoda Y; Dew MA; Simon MA
    J Heart Lung Transplant; 2010 Feb; 29(2):201-8. PubMed ID: 20113910
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Outcome of heart transplantation after bridge-to-transplant strategy using various mechanical circulatory support devices.
    Yoshioka D; Li B; Takayama H; Garan RA; Topkara VK; Han J; Kurlansky P; Yuzefpolskaya M; Colombo PC; Naka Y; Takeda K
    Interact Cardiovasc Thorac Surg; 2017 Dec; 25(6):918-924. PubMed ID: 29106559
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Exercise performance in patients with end-stage heart failure after implantation of a left ventricular assist device and after heart transplantation: an outlook for permanent assisting?
    de Jonge N; Kirkels H; Lahpor JR; Klöpping C; Hulzebos EJ; de la Rivière AB; Robles de Medina EO
    J Am Coll Cardiol; 2001 Jun; 37(7):1794-9. PubMed ID: 11401113
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Clinical Outcome of Heart Transplantation in Osaka University].
    Nakae M; Yoshioka D; Toda K; Kubota K; Saito T; Kawamura T; Kawamura A; Kashiyama N; Matsuura R; Taira M; Shimamura K; Miyagawa S
    Kyobu Geka; 2022 Jan; 75(1):15-20. PubMed ID: 35249072
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Risk factor analysis of late survival after heart transplantation according to donor profile: a multi-institutional retrospective study of 512 transplants.
    Fiorelli AI; Branco JN; Dinkhuysen JJ; Oliveira Junior JL; Pereira TV; Dinardi LF; Santos MM; Dias RR; Pereira LA; Stolf NA
    Transplant Proc; 2012 Oct; 44(8):2469-72. PubMed ID: 23026622
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mechanical circulatory support pathways that maximize post-heart transplant survival.
    Karamlou T; Gelow J; Diggs BS; Tibayan FA; Mudd JM; Guyton SW; Slater MS; Song HK
    Ann Thorac Surg; 2013 Feb; 95(2):480-5; discussion 485. PubMed ID: 22921240
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.